Literature DB >> 30262607

Migraine management: beyond pills.

Benjamin R Wakerley1, Sarah Davies2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30262607      PMCID： PMC6145995          DOI： 10.3399/bjgp18X698969

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  12 in total

Review 1.  Acupuncture for the prevention of episodic migraine.

Authors:  Klaus Linde; Gianni Allais; Benno Brinkhaus; Yutong Fei; Michael Mehring; Emily A Vertosick; Andrew Vickers; Adrian R White
Journal:  Cochrane Database Syst Rev       Date:  2016-06-28

Review 2.  Mindfulness and headache: A "new" old treatment, with new findings.

Authors:  Frank Andrasik; Licia Grazzi; Domenico D'Amico; Emanuela Sansone; Matilde Leonardi; Alberto Raggi; Francisco Salgado-García
Journal:  Cephalalgia       Date:  2016-10-01       Impact factor: 6.292

3.  Acupuncture for Headache. It's Still All Placebo.

Authors:  Seymour Solomon
Journal:  Headache       Date:  2017-01       Impact factor: 5.887

4.  OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.

Authors:  David W Dodick; Catherine C Turkel; Ronald E DeGryse; Sheena K Aurora; Stephen D Silberstein; Richard B Lipton; Hans-Christoph Diener; Mitchell F Brin
Journal:  Headache       Date:  2010-05-07       Impact factor: 5.887

5.  Greater occipital nerve blockade for cluster headache.

Authors:  M F P Peres; M A Stiles; H C Siow; T D Rozen; W B Young; S D Silberstein
Journal:  Cephalalgia       Date:  2002-09       Impact factor: 6.292

6.  Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial.

Authors:  Jean Schoenen; Bart Vandersmissen; Sandrine Jeangette; Luc Herroelen; Michel Vandenheede; Pascale Gérard; Delphine Magis
Journal:  Neurology       Date:  2013-02-06       Impact factor: 9.910

7.  Short-term effects of greater occipital nerve blocks in chronic migraine: A double-blind, randomised, placebo-controlled clinical trial.

Authors:  María L Cuadrado; Ángel Aledo-Serrano; Patricia Navarro; Pedro López-Ruiz; César Fernández-de-Las-Peñas; Inés González-Suárez; Aida Orviz; Cristina Fernández-Pérez
Journal:  Cephalalgia       Date:  2016-06-12       Impact factor: 6.292

8.  Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2016-10-08       Impact factor: 79.321

Review 9.  Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?

Authors:  Amy R Tso; Peter J Goadsby
Journal:  Curr Treat Options Neurol       Date:  2017-08       Impact factor: 3.598

10.  Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study.

Authors:  Peter J Goadsby; Ilse F de Coo; Nicholas Silver; Alok Tyagi; Fayyaz Ahmed; Charly Gaul; Rigmor H Jensen; Hans-Christoph Diener; Kasia Solbach; Andreas Straube; Eric Liebler; Juana Ca Marin; Michel D Ferrari
Journal:  Cephalalgia       Date:  2017-12-12       Impact factor: 6.292
View more
  1 in total

1.  Medication-overuse headache: painkillers are not always the answer.

Authors:  Benjamin R Wakerley
Journal:  Br J Gen Pract       Date:  2020-01-30       Impact factor: 5.386
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.